Location: Larkspur, CA
CIK: 0001425738 · Show all filings
Period: Q1 2016 (← Previous) (Next →)
Filing Date: May 16, 2016
Total Value: $977M (99.7% shares, 0.3% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| FOLD | AMICUS THERAPEUTICS INC | 10,718,420 | $90.57M | 9.3% | $8.45 * | $7.20 | -1.6% | COM | 03152W109 |
| — | MEDIVATION INC | 1,786,599 | $82.15M | 8.4% | $45.98 | $42.86 | — | COM | 58501N101 |
| — | CLOVIS ONCOLOGY INC | 3,099,336 | $59.51M | 6.1% | $19.20 | $34.31 | — | COM | 189464100 |
| PEN | PENUMBRA INC | 1,267,967 | $58.33M | 6.0% | $46.00 | $40.45 | +15.5% | COM | 70975L107 |
| — | ARRAY BIOPHARMA INC | 19,150,650 | $56.49M | 5.8% | $2.95 | $4.81 | — | COM | 04269X105 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 4,320,192 | $47.26M | 4.8% | $10.94 * | $9.44 | -12.6% | COM CL A | 46333X108 |
| — | ATARA BIOTHERAPEUTICS INC | 2,275,765 | $43.31M | 4.4% | $19.03 | $26.79 | — | COM | 046513107 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 478,287 | $39.45M | 4.0% | $82.48 | $81.36 | 0.0% | COM | 09061G101 |
| — | SEATTLE GENETICS INC | 970,121 | $34.04M | 3.5% | $35.09 | $36.43 | — | COM | 812578102 |
| — | SAGE THERAPEUTICS INC | 1,053,018 | $33.76M | 3.5% | $32.06 | $48.49 | — | COM | 78667J108 |
| — | ALLERGAN PLC | 114,448 | $30.68M | 3.1% | $268.03 | $294.75 | — | SHS | G0177J108 |
| — | INTRA CELLULAR THERAPIES INC | 1,056,059 | $29.36M | 3.0% | $27.80 | $29.91 | — | COM | 46116X101 |
| CNC | CENTENE CORP DEL | 470,549 | $28.97M | 3.0% | $61.57 * | $32.98 | -9.5% | COM | 15135B101 |
| — | NANOSTRING TECHNOLOGIES INC | 1,863,035 | $28.36M | 2.9% | $15.22 | $13.87 | — | COM | 63009R109 |
| BSX | BOSTON SCIENTIFIC CORP | 1,332,520 | $25.07M | 2.6% | $18.81 * | $17.92 | -2.0% | COM | 101137107 |
| BKD | BROOKDALE SR LIVING INC | 1,428,931 | $22.69M | 2.3% | $15.88 * | $15.26 | 0.0% | COM | 112463104 |
| — | AETNA INC NEW | 191,625 | $21.53M | 2.2% | $112.35 | $112.35 | — | COM | 00817Y108 |
| MOH | MOLINA HEALTHCARE INC | 329,013 | $21.22M | 2.2% | $64.49 * | $59.38 | 0.0% | COM | 60855R100 |
| — | ENDOLOGIX INC | 2,468,847 | $20.64M | 2.1% | $8.36 | $8.99 | — | COM | 29266S106 |
| — | MODEL N INC | 1,885,359 | $20.3M | 2.1% | $10.77 | $10.67 | — | COM | 607525102 |
| — | PORTOLA PHARMACEUTICALS INC | 889,607 | $18.15M | 1.9% | $20.40 | $44.82 | — | COM | 737010108 |
| WVE | WAVE LIFE SCIENCES LTD | 1,238,273 | $16.96M | 1.7% | $13.70 * | $15.65 | -10.6% | SHS | Y95308105 |
| — | NEURODERM LTD | 1,180,887 | $16.67M | 1.7% | $14.12 | $20.38 | — | ORD SHS | M74231107 |
| INCY | INCYTE CORP | 216,594 | $15.7M | 1.6% | $72.47 * | $109.81 | -32.1% | COM | 45337C102 |
| — | VCA INC | 207,800 | $11.99M | 1.2% | $57.69 | $57.69 | — | COM | 918194101 |
| — | CLOVIS ONCOLOGY INC | 600,000 | $11.52M | 1.2% | $19.20 | — | — | Call | 189464900 |
| CTMX | CYTOMX THERAPEUTICS INC | 729,699 | $9.413M | 1.0% | $12.90 * | $15.82 | -12.2% | COM | 23284F105 |
| — | OXFORD IMMUNOTEC GLOBAL PLC | 876,088 | $8.682M | 0.9% | $9.91 | $17.04 | — | ORD SHS | G6855A103 |
| — | CONFORMIS INC | 792,355 | $8.518M | 0.9% | $10.75 | $11.91 | — | COM | 20717E101 |
| CRL | CHARLES RIV LABS INTL INC | 109,806 | $8.339M | 0.9% | $75.94 * | $72.12 | +2.6% | COM | 159864107 |
| — | NEVRO CORP | 130,571 | $7.346M | 0.8% | $56.26 | $66.24 | — | COM | 64157F103 |
| — | INVITAE CORP | 660,129 | $6.753M | 0.7% | $10.23 | $9.07 | — | COM | 46185L103 |
| — | HEARTWARE INTL INC | 214,771 | $6.748M | 0.7% | $31.42 | $31.42 | — | COM | 422368100 |
| — | PRESS GANEY HLDGS INC | 218,214 | $6.564M | 0.7% | $30.08 | $30.85 | — | COM | 74113L102 |
| — | GW PHARMACEUTICALS PLC | 82,300 | $5.938M | 0.6% | $72.15 | $72.15 | — | ADS | 36197T103 |
| EHTH | EHEALTH INC | 421,742 | $3.96M | 0.4% | $9.39 * | $9.93 | 0.0% | COM | 28238P109 |
| PFE | PFIZER INC | 123,800 | $3.669M | 0.4% | $29.64 * | $20.38 | -8.3% | COM | 717081103 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 263,000 | $3.503M | 0.4% | $13.32 * | $12.54 | 0.0% | COM | 87164F105 |
| — | ARRAY BIOPHARMA INC | 4,000,000 | $3.22M | 0.3% | $0.81 | $1.09 | — | NOTE 3.000% 6/0 | 04269XAA3 |
| — | DURECT CORP | 2,327,137 | $3.142M | 0.3% | $1.35 | $1.95 | — | COM | 266605104 |
| PRQR | PROQR THRAPEUTICS N V | 552,713 | $2.697M | 0.3% | $4.88 * | $16.18 | -68.6% | SHS EURO | N71542109 |
| FATE | FATE THERAPEUTICS INC | 1,486,980 | $2.677M | 0.3% | $1.80 * | $5.78 | -64.4% | COM | 31189P102 |
| IHF | ISHARES TR | 4,520 | $551K | 0.1% | $121.90 | $124.34 | — | US HLTHCR PR ETF | 464288828 |
| — | BLUEPRINT MEDICINES CORP | 27,055 | $488K | 0.0% | $18.04 | $25.57 | — | COM | 09627Y109 |
| — | AXOVANT SCIENCES LTD | 10,000 | $115K | 0.0% | $11.50 | $11.50 | — | COM | G0750W104 |
| AUPH | AURINIA PHARMACEUTICALS INC | 19,710 | $58,000 | 0.0% | $2.94 * | $2.67 | -9.4% | COM | 05156V102 |
| — | CHEMOCENTRYX INC | 10,000 | $25,000 | 0.0% | $2.50 | $8.10 | — | COM | 16383L106 |